vimarsana.com

Biocon Q4: The company's revenue from operations fell 15 percent to Rs 2947.3 crore from last year's Rs 2542.8 crore in the same period.

Related Keywords

India ,Biocon Biologics ,Viatris Inc ,Biocon ,Compulsorily Convertible Preference Shares ,

© 2024 Vimarsana

vimarsana.com © 2020. All Rights Reserved.